Literature DB >> 8902393

Graft-versus-host effect after allogeneic hematopoietic stem cell transplantation: GVHD and GVL.

R A Nash1, R Storb.   

Abstract

The development of a graft-versus-host reaction after allogeneic hematopoietic stem cell transplantation is an important determinant of the transplant outcome. A better understanding and improved management of the graft-versus-host reaction should allow improved prevention and treatment of graft-versus-host disease and the development of new strategies to enhance a graft-versus-leukemia effect and to decrease the incidence of leukemic relapse after transplantation.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8902393     DOI： 10.1016/s0952-7915(96)80085-9

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN： 0952-7915            Impact factor:   7.486


  11 in total

1.  Inter-strain tissue-infiltrating T cell responses to minor histocompatibility antigens involved in graft-versus-host disease as determined by Vbeta spectratype analysis.

Authors:  Jenny Zilberberg; Danielle McElhaugh; Loise N Gichuru; Robert Korngold; Thea M Friedman
Journal:  J Immunol       Date:  2008-04-15       Impact factor: 5.422

2.  Dynamical System Modeling of Immune Reconstitution after Allogeneic Stem Cell Transplantation Identifies Patients at Risk for Adverse Outcomes.

Authors:  Amir A Toor; Roy T Sabo; Catherine H Roberts; Bonny L Moore; Salman R Salman; Allison F Scalora; May T Aziz; Ali S Shubar Ali; Charles E Hall; Jeremy Meier; Radhika M Thorn; Elaine Wang; Shiyu Song; Kristin Miller; Kathryn Rizzo; William B Clark; John M McCarty; Harold M Chung; Masoud H Manjili; Michael C Neale
Journal:  Biol Blood Marrow Transplant       Date:  2015-04-04       Impact factor: 5.742

3.  The impact of graft-versus-host disease prophylaxis in reduced-intensity conditioning allogeneic stem cell transplant in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

Authors:  Marie Thérèse Rubio; Myriam Labopin; Didier Blaise; Gerard Socié; Rafael Rojas Contreras; Patrice Chevallier; Miguel A Sanz; Stéphane Vigouroux; Anne Huynh; Avichai Shimoni; Claude-Eric Bulabois; Nerea Caminos; Lucía López-Corral; Arnon Nagler; Mohamad Mohty
Journal:  Haematologica       Date:  2015-03-13       Impact factor: 9.941

4.  Pre-transplant donor CD4- invariant NKT cell expansion capacity predicts the occurrence of acute graft-versus-host disease.

Authors:  M-T Rubio; M Bouillié; N Bouazza; T Coman; H Trebeden-Nègre; A Gomez; F Suarez; D Sibon; A Brignier; E Paubelle; S Nguyen-Khoc; M Cavazzana; O Lantz; M Mohty; S Urien; O Hermine
Journal:  Leukemia       Date:  2016-10-14       Impact factor: 11.528

5.  A phase I study of nonmyeloablative chemotherapy and adoptive transfer of autologous tumor antigen-specific T lymphocytes in patients with metastatic melanoma.

Authors:  Mark E Dudley; John R Wunderlich; James C Yang; Patrick Hwu; Douglas J Schwartzentruber; Suzanne L Topalian; Richard M Sherry; Francesco M Marincola; Susan F Leitman; Claudia A Seipp; Linda Rogers-Freezer; Kathleen E Morton; Azam Nahvi; Sharon A Mavroukakis; Donald E White; Steven A Rosenberg
Journal:  J Immunother       Date:  2002 May-Jun       Impact factor: 4.456

6.  Differential roles of IL-1 and TNF-alpha on graft-versus-host disease and graft versus leukemia.

Authors:  G R Hill; T Teshima; A Gerbitz; L Pan; K R Cooke; Y S Brinson; J M Crawford; J L Ferrara
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

7.  Definitive separation of graft-versus-leukemia- and graft-versus-host-specific CD4+ T cells by virtue of their receptor beta loci sequences.

Authors:  J Michalek; R H Collins; H P Durrani; P Vaclavkova; L E Ruff; D C Douek; E S Vitetta
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-16       Impact factor: 11.205

Review 8.  Allo-reactive T cells for the treatment of hematological malignancies.

Authors:  J H F Falkenburg; I Jedema
Journal:  Mol Oncol       Date:  2015-10-24       Impact factor: 6.603

Review 9.  Graft-Versus-Solid-Tumor Effect: From Hematopoietic Stem Cell Transplantation to Adoptive Cell Therapies.

Authors:  Stefan Barisic; Richard W Childs
Journal:  Stem Cells       Date:  2022-06-22       Impact factor: 5.845

10.  Incubation of Immune Cell Grafts With MAX.16H5 IgG1 Anti-Human CD4 Antibody Prolonged Survival After Hematopoietic Stem Cell Transplantation in a Mouse Model for Fms Like Tyrosine Kinase 3 Positive Acute Myeloid Leukemia.

Authors:  Nadja Hilger; Claudia Mueller; Lilly Stahl; Anne M Mueller; Bianca Zoennchen; Sarah Dluczek; Christoph Halbich; Claudia Wickenhauser; Dennis Gerloff; Alexander A Wurm; Gerhard Behre; Anna Kretschmer; Stephan Fricke
Journal:  Front Immunol       Date:  2018-10-22       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.